Rajendra Shanmugarajah, Sharma Prateek
Gastro-Intestinal Viral Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, Sydney, NSW 2170, Australia.
South Western Sydney Clinical School, University of New South Wales, Kensington, Sydney, NSW 2052, Australia.
Cancers (Basel). 2023 Jan 31;15(3):873. doi: 10.3390/cancers15030873.
Esophageal cancer is a relatively common malignancy worldwide with a high mortality (5-year survival of <15%). Despite screening, surveillance, improved imaging and treatment, the exponential rise in OAC continues. The strongest risk factors for OAC are chronic heartburn and metaplastic transformation of the lower third of the esophagus (Barrett's esophagus). The risk profile includes Caucasian race, male gender older age, obesity and smoking. Although the tumor risk in BO has been progressively revised downwards, the exponential rise in OAC remains unchecked. This paradox points to an unidentified missing link. Relatively recently, we provided the world's initial data for a strong association of biologically relevant hr-HPV with BD and OAC. Since then, systematic reviews and meta-analysis have documented HPV DNA prevalence rates in OAC of between 13 to 35%. In this review, we provide some evidence for a probable causal relationship between hr-HPV and OAC. This is challenging given the multifactorial etiology and long latency. Increasingly, high-risk HPV (hr-HPV) is regarded as a risk factor for OAC. This discovery will aid identification of a sub-group of high-risk progressors to esophageal cancer by surveillance and the development of effective preventive strategies including vaccination.
食管癌是全球较为常见的恶性肿瘤,死亡率很高(5年生存率<15%)。尽管进行了筛查、监测、改进成像技术和治疗,但食管腺癌(OAC)仍呈指数级上升。OAC最强的风险因素是慢性烧心和食管下三分之一的化生转变(巴雷特食管)。风险特征包括白种人、男性、老年、肥胖和吸烟。尽管巴雷特食管(BO)的肿瘤风险已逐渐下调,但OAC的指数级上升仍未得到控制。这一矛盾表明存在一个尚未确定的缺失环节。相对较近的时候,我们提供了世界上关于生物学相关的高危人乳头瘤病毒(hr-HPV)与巴雷特食管和OAC之间存在强关联的初始数据。从那时起,系统评价和荟萃分析记录了OAC中HPV DNA的流行率在13%至35%之间。在本综述中,我们提供了一些证据证明hr-HPV与OAC之间可能存在因果关系。鉴于其多因素病因和长潜伏期,这具有挑战性。高危人乳头瘤病毒(hr-HPV)越来越被视为OAC的一个风险因素。这一发现将有助于通过监测识别出食管癌高危进展亚组,并制定包括疫苗接种在内的有效预防策略。